European Union - English - EMA (European Medicines Agency)

novo nordisk a/s - turoctocog alfa pegol - hemophilia a - antihemorrhagics - treatment and prophylaxis of bleeding in patients 12 years and above with haemophilia a (congenital factor viii deficiency).

Israel - English - Ministry of Health

novo nordisk ltd., israel - turoctocog alfa pegol - powder and solvent for solution for injection - turoctocog alfa pegol 1000 iu/vial - treatment and prophylaxis of bleeding in previously treated patients with haemophilia a (congenital factor viii disorder).esperoct® does not contain pharmacologically active quantities of von willebrand factor and is, therefore, unsuitable for the treatment of von willebrand disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - turoctocog alfa pegol, quantity: 3000 iu - injection, solvent for - excipient ingredients: sodium chloride; water for injections - esperoct, is a long-acting recombinant factor viii concentrate indicated for use in previously treated patients with haemophilia a for:,? routine prophylactic treatment to prevent or reduce the frequency of bleeding episodes,? on-demand treatment and control of bleeding episodes,? peri-operative management of bleeding (surgical prophylaxis),esperoct does not contain von willebrand factor, and therefore is not indicated in patients with von willebrand?s disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - turoctocog alfa pegol, quantity: 500 iu - injection, solvent for - excipient ingredients: sodium chloride; water for injections - esperoct, is a long-acting recombinant factor viii concentrate indicated for use in previously treated patients with haemophilia a for:,? routine prophylactic treatment to prevent or reduce the frequency of bleeding episodes,? on-demand treatment and control of bleeding episodes,? peri-operative management of bleeding (surgical prophylaxis),esperoct does not contain von willebrand factor, and therefore is not indicated in patients with von willebrand?s disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - turoctocog alfa pegol, quantity: 1000 iu - injection, solvent for - excipient ingredients: water for injections; sodium chloride - esperoct, is a long-acting recombinant factor viii concentrate indicated for use in previously treated patients with haemophilia a for:,? routine prophylactic treatment to prevent or reduce the frequency of bleeding episodes,? on-demand treatment and control of bleeding episodes,? peri-operative management of bleeding (surgical prophylaxis),esperoct does not contain von willebrand factor, and therefore is not indicated in patients with von willebrand?s disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - turoctocog alfa pegol, quantity: 2000 iu - injection, solvent for - excipient ingredients: water for injections; sodium chloride - esperoct, is a long-acting recombinant factor viii concentrate indicated for use in previously treated patients with haemophilia a for:,? routine prophylactic treatment to prevent or reduce the frequency of bleeding episodes,? on-demand treatment and control of bleeding episodes,? peri-operative management of bleeding (surgical prophylaxis),esperoct does not contain von willebrand factor, and therefore is not indicated in patients with von willebrand?s disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - turoctocog alfa pegol, quantity: 1500 iu - injection, solvent for - excipient ingredients: sodium chloride; water for injections - esperoct, is a long-acting recombinant factor viii concentrate indicated for use in previously treated patients with haemophilia a for:,? routine prophylactic treatment to prevent or reduce the frequency of bleeding episodes,? on-demand treatment and control of bleeding episodes,? peri-operative management of bleeding (surgical prophylaxis),esperoct does not contain von willebrand factor, and therefore is not indicated in patients with von willebrand?s disease.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

novo nordisk, denmark - turoctocog alfa pegol - powder and solvent for solution for injection - 2000 iu

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

novo nordisk, denmark - turoctocog alfa pegol - powder and solvent for solution for injection - 500 iu

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

novo nordisk, denmark - turoctocog alfa pegol - powder and solvent for solution for injection - 1000 iu